SYL040012

DRUG3 trials

Sponsors

Sylentis, S.A.

Conditions

GlaucomaOcular HypertensionOpen Angle Glaucoma

Phase 1

Tolerance and Effect on Intraocular Pressure After Administration of SYL040012

CompletedNCT00990743

Sylentis, S.A.Glaucoma, Ocular Hypertension

Start: 2009-09-30End: 2010-06-30Updated: 2010-10-22

SYL040012. Tolerance and Effect on Intraocular Pressure in Subjects With Intraocular Pressure (IOP) >= 21 mm Hg

CompletedNCT01227291

Sylentis, S.A.Glaucoma, Ocular Hypertension

Start: 2010-10-31End: 2012-09-30Updated: 2012-09-27

Phase 2

Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma

CompletedNCT01739244

Sylentis, S.A.Ocular Hypertension, Open Angle Glaucoma

Start: 2012-07-31End: 2013-05-31Updated: 2013-06-10